Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

被引:4
作者
Fadavi, Pedram [1 ]
Arefpour, Amir Mohammad [1 ]
Hariri, Ramyar [1 ]
Vasheghani, Maryam [1 ]
Garousi, Maryam [1 ]
Taghizadeh-Hesary, Farzad [2 ]
机构
[1] Iran Univ Med Sci, Radiat Oncol Dept, Tehran 1449614535, Iran
[2] Shahid Beheshti Univ Med Sci, Radiat Oncol Dept, Tehran, Iran
来源
CLINICAL CASE REPORTS | 2021年 / 9卷 / 10期
关键词
aneurysmal bone cyst; denosumab; management; RANK ligand; resistant;
D O I
10.1002/ccr3.4993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor-kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.
引用
收藏
页数:6
相关论文
共 20 条
[1]   Denosumab Therapy in the Management of Aneurysmal Bone Cysts: A Comprehensive Literature Review [J].
Alhumaid, Ibrahim ;
Abu-Zaid, Ahmed .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)
[2]  
Bahk WJ., 2015, AM J CLIN PATHOL, V143, P823, DOI [10.1309/ajcp33yddjkfftsv, DOI 10.1309/AJCP33YDDJKFFTSV]
[3]  
Bajpai M, 2018, JCPSP-J COLL PHYSICI, V28, P174, DOI 10.29271/jcpsp.2018.02.174
[4]  
Borges D., 2018, ANEURYSMAL BONE CYST
[5]   Percutaneous Radionuclide Ablation of Axial Aneurysmal Bone Cysts [J].
Bush, Charles H. ;
Adler, Zachary ;
Drane, Walter E. ;
Tamurian, Robert ;
Scarborough, Mark T. ;
Gibbs, Charles P. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (01) :W84-W90
[6]   Treatment of aneurysmal bone cysts by percutaneous CT-guided injection of calcitonin and steroid [J].
Chang, Connie Y. ;
Kattapuram, Susan V. ;
Huang, Ambrose J. ;
Simeone, F. Joseph ;
Torriani, Martin ;
Bredella, Miriam A. .
SKELETAL RADIOLOGY, 2017, 46 (01) :35-40
[7]   Aneurysmal bone cyst: results of an off label treatment with Denosumab [J].
Duerr, Hans Roland ;
Grahneis, Ferdinand ;
Baur-Melnyk, Andrea ;
Knoesel, Thomas ;
Birkenmaier, Christof ;
Jansson, Volkmar ;
Klein, Alexander .
BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (01)
[8]  
Elsayad K, 2017, STRAHLENTHER ONKOL, V193, P332, DOI 10.1007/s00066-016-1085-6
[9]  
Ghermandi R, 2016, EUR REV MED PHARMACO, V20, P3692
[10]  
Hildebrand GK., 2021, STATPEARLS